基本信息
产品名称：Daclizumab (anti-IL2RA)
规格或纯度：无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
应用：Flow Cytometry, ELISA, Functional Assay, Animal Model
特异性：IL2RA
种属反应性：人(Human), 小鼠(Mouse), 大鼠(Rat), 恒河猴(Rhesus monkey)
偶联：Unconjugated
产品属性
克隆类型：重组抗体
Format：Whole IgG
亚型：Human IgG1
轻链亚型：kappa
SDS-PAGE：27.1 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 178.6 kDa, under non-reducing conditions.
纯化方法：Protein A purified
物理外观：Liquid
储存缓冲液：Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂：No
浓度：见COA
储存温度：-80℃储存,避免反复冻融
运输条件：特低温运输
稳定性与储存：在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
纯度：>95%
CAS编号和信息：152923-56-3
化学和物理性质
功能和特点
宿主种属：人(Human)
种属反应性：人(Human), 小鼠(Mouse), 大鼠(Rat), 恒河猴(Rhesus monkey)
偶联：Unconjugated
图片
>
Flow Cytometry: Daclizumab (anti-IL2RA) (Ab170892)
Daclizumab (anti-IL2RA) (Ab170892) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood mononuclear lymphocytes labelling IL2RA (red) with Daclizumab (anti-IL2RA) (Ab170892). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
>
SEC: Daclizumab (anti-IL2RA) (Ab170892)
Daclizumab (anti-IL2RA) (Ab170892) - SEC
The purity of Daclizumab (anti-IL2RA) (Ab170892) is more than 95% verified by HPLC.
>
ELISA: Daclizumab (anti-IL2RA) (Ab170892)
Daclizumab (anti-IL2RA) (Ab170892) - ELISA
Immobilized TARGET at 2 μg/mL can bind Daclizumab (anti-IL2RA) (Ab170892) with the EC₅₀ of 31.47 ng/mL.
查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/Ab170892.html
关键字： 达克珠单抗 ; 达利珠单抗 ; 达克珠单抗(抗 IL2RA);Interleukin 2 receptor alpha chain antibody
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代码：688179），专注于科研试剂的研发、生产和销售，已陆续建立多个工厂和研发中心。作为领军企业，阿拉丁始终坚持质量第一，连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种，SKU总数超过46万，产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域，是国内少数化学试剂到生物试剂全面发展的国产试剂品牌，产品同步发布在我们国内外电商平台。